JPRN-UMIN000006024招募中未知
Effect of dipeptidyl peptidase-4 inhibitor to the additional secretion of insulin in type 2 diabetic patients on hemodialysis - Effect of dipeptidyl peptidase-4 inhibitor to the additional secretion of insulin in type 2 diabetic patients on hemodialysis
Chibune general hospital0 个研究点目标入组 5 人开始时间: 2011年7月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Type 2 diabetic patients who received insulin therapy or oral hypoglycemic agents or Liraglutide. (2) Type 2 diabetic patients who have been treated with DPP-4 inhibitor. (3) Type 1 diabetic patients. (4) Patients who develop serious hyperglycemia or diabetic ketoacidosis. (5) Patients with nephrotic syndrome. (6) Patients with treatments of steroids or immunosuppressive agents or antifungal or HIV protease inhibitors. (7) Patients with severe complications in cardiovascular system within 6 months before study entry. (8) Patients with liver diseases. (9) Patients with cancer diseases. (10) Patients with pregnancy , possibility of pregnancy . (11) Patients who are deemed to be inappropriate by the investigators.
研究者
相似试验
已完成
不适用
The impact of dipeptidyl peptidase-4 inhibitor on coronary microvascular function in patients with type2 diabetes mellitusType 2 diabetic patients with stable angina pectoris who undergo percutaneous coronary interventionJPRN-UMIN000004390Cardiovascular Division, Hyogo College of Medicine40
已完成
不适用
Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients.JPRN-UMIN000007255Center for Cardiovascular Interventions,Chiba University Hospital128
已完成
不适用
Effects of dipeptidyl peptidase-4 (DPP-4) inhibitor, alogliptin, on coronary atherosclerosis in patients with type 2 diabetes mellitusPatients with type 2 diabetes mellitus who were suspected as having ischemic heart diseaseJPRN-UMIN000015381Kanagawa PTCA Conference50
尚未招募
不适用
Effect of Dipeptidyl Peptidase-4 Inhibitor Teneligliptin on Forearm Endothelial Function in Diabeticsdiabetic patientJPRN-jRCT1091220223Bonpei Takase30
尚未招募
不适用
The inhibitory effects of the DPP-4 inhibitor for progression of diabetic nephropathy, in the patients with type 2 diabetes in Japan.The CKD patients with type 2 diabetesJPRN-UMIN000011101Saitama Medical Center, Saitama Medical University50